Work

Safety profile of recombinant canarypox HIV vaccines

Year: 2003

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2003.08.023

Authors: Guy de Bruyn, Anthony J Rossini, Ya-Lin Chiu, Drienna Holman, Marnie L Elizaga, Sharon E Frey, Donald Burke, Thomas G Evans, Lawrence Corey, Michael C Keefer

Institutions: Fred Hutch Cancer Center, University of Washington, Saint Louis University, Johns Hopkins University, University of Rochester Medicine, University of Rochester

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Institute of Allergy and Infectious Diseases

Awards: G1032946488, G1295452613, G1309671147, HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER, HIV VACCINE CLINICAL TRIALS UNIT, HIV VACCINE CLINICAL TRIALS UNIT, G2395925390, G31852639, G3487907617, G3647493210, (HVTN) HIV VACCINE TRIAL UNITS, G4402914190, HIV VACCINE TRIAL CLINICAL UNIT, HIV VACCINE TRAILS NETWORK LEADERSHIP GROUP, G5082750242, IMMUNOLOGY AND MOLECULAR VIROLOGY OF ACUTE HIV INFECTION, G687681150, SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT, HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP

OpenAlex ID: W2072191236

FWCI: 2.761

Cites: 25

Cited by: 69

Related to: 10